The Chan Zuckerberg Initiative has announced grants totaling $4.5 million over eighteen months in support of innovative research focused on neurodegenerative disorders such as Alzheimer's, Parkinson's, and ALS.
Awarded through the interdisciplinary Neurodegeneration Challenge Network, the grants will support thirty pairs of researchers studying common neurodegenerative diseases, Huntington’s disease, spinocerebellar ataxia, multiple sclerosis, glaucoma, and rare genetically based pediatric neurological disorders. This year, 87 percent of the collaborations receiving grants feature an early-career researcher, while 20 percent are composed of two early-career researchers. The awards mark the first phase of the project, whereby research pairs receive seed funds for initial pilot projects. In phase two, successful project teams will be eligible to apply for additional grant awards of $1.6 million over four years.
"We are excited to welcome the Collaborative Pairs grantees to CZI's Neurodegeneration Challenge Network and are hopeful that the discoveries these researchers make help us understand these devastating disorders," said CZI head of science Cori Bargmann. "With this collaborative network, we’re also thrilled to support early- and mid-career scientists who bring new approaches and insights to the neurodegeneration field."
For a complete list of awardees, see the Chan Zuckerberg Initiative website.